Centessa Pharmaceuticals (CNTA)

• Market cap: $3.58B
• 1 day: 2.93%
• 5 days: 1.68%
• 1 month: 10.13%
• 3 months: -9.18%
• 6 months: 41.73%
• Year to date: 2.36%
• 1 year: 34.72%
• 5 years: 11.49%
• 10 years: 11.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Employees: 114